BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 103 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 0.50 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $188,000 | +113.6% | 18,459 | +0.6% | 0.00% | – |
| Q1 2018 | $88,000 | -11.1% | 18,350 | +3.1% | 0.00% | -100.0% |
| Q2 2017 | $99,000 | +450.0% | 17,800 | +714.6% | 0.00% | – |
| Q1 2017 | $18,000 | -89.0% | 2,185 | -91.6% | 0.00% | -100.0% |
| Q4 2016 | $164,000 | +51.9% | 25,950 | +6.4% | 0.00% | 0.0% |
| Q3 2016 | $108,000 | +129.8% | 24,400 | +48.8% | 0.00% | – |
| Q2 2016 | $47,000 | +34.3% | 16,400 | +31.2% | 0.00% | – |
| Q1 2016 | $35,000 | -70.3% | 12,500 | +9.6% | 0.00% | -100.0% |
| Q4 2015 | $118,000 | +42.2% | 11,400 | +56.2% | 0.00% | 0.0% |
| Q3 2015 | $83,000 | +1085.7% | 7,300 | +812.5% | 0.00% | – |
| Q1 2015 | $7,000 | -30.0% | 800 | 0.0% | 0.00% | – |
| Q4 2014 | $10,000 | -9.1% | 800 | -27.6% | 0.00% | – |
| Q3 2014 | $11,000 | +10.0% | 1,105 | +37.3% | 0.00% | – |
| Q2 2014 | $10,000 | +11.1% | 805 | 0.0% | 0.00% | – |
| Q1 2014 | $9,000 | +50.0% | 805 | +0.6% | 0.00% | – |
| Q4 2013 | $6,000 | 0.0% | 800 | 0.0% | 0.00% | – |
| Q3 2013 | $6,000 | +500.0% | 800 | 0.0% | 0.00% | – |
| Q2 2013 | $1,000 | – | 800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 3,846,154 | $27,230,770 | 26.28% |
| Prosight Management, LP | 2,408,135 | $17,049,596 | 5.40% |
| Kynam Capital Management, LP | 3,133,193 | $22,183,006 | 3.63% |
| Saturn V Capital Management LP | 982,458 | $6,955,803 | 2.91% |
| AlphaCentric Advisors LLC | 649,000 | $4,594,920 | 2.61% |
| TANG CAPITAL MANAGEMENT LLC | 1,800,000 | $12,744,000 | 1.80% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 791,671 | $5,605,031 | 1.70% |
| Eversept Partners, LP | 2,479,103 | $17,552,049 | 1.48% |
| DAFNA Capital Management LLC | 652,000 | $4,616,160 | 1.44% |
| Avoro Capital Advisors LLC | 11,550,000 | $81,774,000 | 1.28% |